03 June, 2017
Company shares have been seen trading -48.07% off of the 52 week high and 3.95% away from the 52 week low.
A few days ago, the CEO & Chairman of Opko Health Inc, Mr. Phillip Frost, made a purchase of a substantial amount of shares - 18,600 , totalling $116,773 U.S. Dollars, calculated based on $6.3 a share. The SEC filing shows that FROST PHILLIP MD ET AL performed a purchase of 207,700 shares. Shares have dropped -42.01% over the trailing 6 months. The insider FROST PHILLIP MD ET AL bought $342,042. The stock was acquired at an average price of $6.38 per share, for a total transaction of $165,880.00. Finally, Turner Investments LLC acquired a new position in shares of Opko Health during the fourth quarter valued at $372,000. The shares were bought at an average price of $6.42 per share, with a total value of $270,924.00.
On Friday, May 26th, Phillip Md Et Al Frost purchased 64,600 shares of Opko Health stock. The shares were bought at an average price of $6.43 per share, with a total value of $771,600.00.
On Friday, May 19th, Phillip Md Et Al Frost purchased 9,200 shares of Opko Health stock.
On Thursday, May 18th, Phillip Md Et Al Frost purchased 20,000 shares of Opko Health stock. The stock was acquired at an average price of $6.59 per share, for a total transaction of $131,800.00.
On Wednesday, May 17th, Phillip Md Et Al Frost acquired 70,800 shares of Opko Health stock. The shares were bought at an average price of $6.54 per share, with a total value of $463,032.00. The company's stock had a trading volume of 2,862,495 shares. The stock was purchased at an average price of $6.93 per share, for a total transaction of $138,600.00. Opko Health, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Executive VP-Administration Rubin Steven D has acquired 2,000 shares of Opko Health, Inc. (NASDAQ:OPK) observed rebound of 0.32% since bottoming out at $6.25 on May. Alpha One also assigned headlines about the biotechnology company an impact score of 61 out of 100, meaning that recent news coverage is somewhat likely to have an effect on the company's share price in the next several days. The company has a market cap of $3.45B and its 12 month revenue was nearly $1.23B. The stock has a 50 day moving average price of $7.11 and a 200-day moving average price of $8.67.
Opko Health Inc (NASDAQ:OPK) 52-week high price stands at $12.15 and low price stands at $6.07, its price distance from 52-week high is -47.16% while its distance from 52-week low price is 5.77%. 5671738 shares were traded on Opko Health Inc's last session. They expect $0.14 EPS, up 27.27% or $0.03 from last year's $0.11 per share. Opko Health had a negative net margin of 0.81% and a negative return on equity of 0.49%. The firm's quarterly revenue was up 1.8% on a year-over-year basis.
For the past 5 years, EQT Corporation's EPS growth has been almost -24.3%.
Analysts' mean recommendation for Opko Health, Inc.
ILLEGAL ACTIVITY WARNING: This article was first published by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this piece on another domain, it was illegally stolen and republished in violation of United States and global copyright & trademark laws. (NASDAQ:OPK). Janney Montgomery Scott Ltd Liability Corp reported 26,471 shares or 0% of all its holdings. TheStreet lowered Opko Health from a "c-" rating to a "d+" rating in a research note on Wednesday, February 1st.
03/31/2016 - Opko Health Inc had its "outperform" rating reiterated by analysts at Barrington Research. They now have a United States dollars 25 price target on the stock.
Opko Health Inc (OPK) now has P/E (Price to Earnings) ratio of 0 while the company's industry has 14.06 P/E and the sector P/E is 17.21.
Taking a broader look brokerage firms' analysts on the street with an expectant view have Opko Health Inc (NASDAQ:OPK) high price target of $19.5 and with a conservative view have low price target of $8. A rating of 4 or 5 would represent a Sell recommendation. This company shares are 110.28% off its target price of $13.5 and the current market capitalization stands at $3.6B. AQR Capital Management LLC purchased a new stake in Opko Health during the fourth quarter worth approximately $105,000. Dimensional Fund Advisors LP boosted its position in shares of Opko Health by 2.0% in the fourth quarter. He owns 63.93% of the -company's market cap with a total of 349.20 million shares. Timber Hill LLC bought a new position in shares of Opko Health during the first quarter worth about $114,000.
